EirGenix (TPE:6589) Short Interest


TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$49.70
GF Value NT$92.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:6589 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, EirGenix's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EirGenix Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EirGenix's Short Interest distribution charts can be found below:

* The bar in red indicates where EirGenix's Short Interest falls into.


TPE:6589
58GF Score
EirGenix Inc TPE:6589
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$49.70 is trading 46.1% below its estimated GF Value™ of NT$92.26. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • Short Interest:
  • GF Value™: NT$92.26 vs. price of NT$49.70 (46.1% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$49.70
Price
NT$92.26
GF Value